NOTICIES

NOTICIESNOTICIES

14
Dec

European Innovation Council backs CRG start-up to further efforts in treating leading cause of cancer mortality worldwide

28
Nov
Image 1. Mitotic spindles with microtubules (red) attached to chromosomes (blue) during cell division. Cells with normal TTLL11 function (right) have normal rates of microtubule polyglutamylation (green) while cells without TTLL11 (left) are unmodified. Isabelle Vernos

The enzyme’s activity was found to be compromised in human cancer cells

RECERCA
24
Nov

Luciano Di Croce and Isabelle Vernos will identify and validate new therapeutics targets for breast cancer and midline gliomas

FINANçAMENT
23
Nov

Visit aimed to foster collaboration between pharma companies and research centres

22
Nov

Lars Velten and Arnau Sebe Pedros have been recognised by the prestigious organisation

DISTINCIONS I PREMIS
27
Oct
Image of a mouse pancreatic islet, regions in the pancreas that contain beta cells which secret insulin. The HASTER regulatory element has been knocked out in this mouse, resulting in changes to beta cell function that cause diabetes. Credit: Miguel A Garriga/

Studying noncoding RNAs opens new avenues to understand human disease 

RECERCA
25
Oct
The success of the start-up highlights the CRG's commitment to technology transfer and investment in the economy
EMPRESA
19
Oct

The findings pave the way for the development of routine medical tests that predict the onset of the disease before symptoms appear

RECERCA
13
Oct

New genome imaging technique is “like upgrading from the Hubble to the James Webb” 

RECERCA
06
Oct

The grant will help determine whether researchers can find new ways to treat an aggressive breast cancer

Pages